IR-Med, Inc. Files 8-K on Material Agreement & Equity Sales
Ticker: IRME · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $0.013, $0.05, $64,754, $20,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
TL;DR
IR-Med (IRMD) filed an 8-K for a material agreement and equity sales. Watch for updates.
AI Summary
IR-Med, Inc. filed an 8-K on August 28, 2025, reporting a material definitive agreement and unregistered sales of equity securities. The company, formerly known as International Display Advertising, Inc., is incorporated in Nevada and has its principal executive offices in Rosh Pina, Israel.
Why It Matters
This filing indicates significant corporate activity, including a new material agreement and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can introduce financial and operational risks.
Key Numbers
- 000-56492 — SEC File Number (Identifies the company's filing with the SEC.)
- 84-4516398 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- IR-Med, Inc. (company) — Filer
- International Display Advertising, Inc. (company) — Former company name
- August 28, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Rosh Pina Israel (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement?
The filing does not specify the details of the material definitive agreement, only that it is a reportable event.
What type of equity securities were sold unregistered?
The filing mentions unregistered sales of equity securities but does not specify the type or amount.
When did the company change its name from International Display Advertising, Inc.?
The company changed its name on January 5, 2021.
What is IR-Med, Inc.'s primary business?
IR-Med, Inc. is classified under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Stats: 1,002 words · 4 min read · ~3 pages · Grade level 11.5 · Accepted 2025-09-02 19:24:35
Key Financial Figures
- $0.001 — f the Company's common stock, par value $0.001 per share, (the "Common Stock"), at a p
- $0.013 — Common Stock"), at a per share price of $0.013 and a warrant to purchase up to an addi
- $0.05 — ants") at a per share exercise price of $0.05 (the "Exercise Price"). The Offering cl
- $64,754 — ny received aggregate gross proceeds of $64,754. In connection with the Offering, three
- $20,000 — rs: (i) Oded Bashan, Director, invested $20,000, receiving 1,538,461 shares of Common S
- $10,000 — re, (ii) Ron Mayron, Director, invested $10,000, receiving 769,231 shares of Common Sto
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex4-1.htm (EX-4.1) — 116KB
- ex10-1.htm (EX-10.1) — 198KB
- ex4-1_001.jpg (GRAPHIC) — 14KB
- 0001493152-25-012577.txt ( ) — 584KB
- irme-20250828.xsd (EX-101.SCH) — 3KB
- irme-20250828_lab.xml (EX-101.LAB) — 33KB
- irme-20250828_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IR-Med, Inc. By: /s/ Sharon Levkoviz Name: Sharon Levkoviz Title: Chief Financial Officer Date: September 2, 2025